Inscription Capital, LLC

Position in TAK — Takeda Pharmaceutical Co Ltd

CIK 1767868 HOUSTON, TX

Position in TAK

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$344,324

-$63,319 QoQ

Shares Held

21,480

-2.4% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#161

of 378 holders

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 78% Shared 0% None 22%

Healthcare · as of Jun 30, 2026

Inscription Capital, LLC holds $1,295,045 across 5 Drug Manufacturers - Specialty & Generic names. TAK ranks #1 (26.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TAK	Takeda Pharmaceutical Co Ltd This page	21,480	$344,324
2	ELAN	Elanco Animal Health Inc	13,042	$320,963
3	ZTS	Zoetis Inc.	4,057	$291,536
4	ANIK	Anika Therapeutics, Inc.	13,750	$201,162
5	BCRX	Biocryst Pharmaceuticals Inc	13,706	$137,060

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$344,324	21,480	-2.4%	Shares	Sole	2026-08-13
2026-03-31	$407,643	22,011	+3.7%	Shares	Sole	2026-04-20
2025-12-31	$331,022	21,233	+0.1%	Shares	Sole	2026-01-29
2025-09-30	$310,602	21,216	+13.7%	Shares	Sole	2025-10-29
2025-06-30	$288,468	18,659	-14.5%	Shares	Sole	2025-08-12
2025-03-31	$324,448	21,819	-3.7%	Shares	Sole	2025-04-17
2024-09-30	$322,267	22,663	+0.4%	Shares	Sole	2024-10-24
2024-06-30	$292,042	22,569	+3.4%	Shares	Sole	2024-07-17
2024-03-31	$303,065	21,819	—	Shares	Sole	2024-07-17
No filing history on record for this holder in this stock.